Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2024

    read more

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Esophagus to Small Intestine

    Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: Systematic review and network meta-analysis

    Gut. 2023;72(2):264–74

    Barberio B, Gracie DJ, Black CJ, Ford AC

    Go to article

    Esophagus to Small Intestine

    Top-down versus step-up strategies to prevent postoperative recurrence in Crohn’s disease

    Inflamm Bowel Dis. 2023;29(2):185–94

    Buisson A, Blanco L, Manlay L, Reymond M, Dapoigny M, Rouquette O, Dubois A, Pereira B

    Go to article

    Colon to Rectum

    Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): A prospective, multicenter cohort study

    Lancet Gastroenterol Hepatol. 2023;8(1):31–42

    Atia O, Shavit-Brunschwig Z, Mould DR, Stein R, Matar M, Aloi M, Ledder O, Focht G, Urlep D, Hyams J, Broide E, Weiss B, Levine J, Russell RK, Turner D

    Go to article

    Colon to Rectum

    Rapid and sustained symptom relief in patients with ulcerative colitis treated with filgotinib: Data from the phase 2b/3 SELECTION trial

    Am J Gastroenterol. 2023;118(1):138–47

    Danese S, Ferrante M, Feagan BG, Peyrin-Biroulet L, Hibi T, Sandborn WJ, Schreiber S, Ritter T, Loftus EV, Jr., Rogler G, Oortwijn A, Yun C, Le Brun FO, Dinoso J, Hsieh J, Vermeire S

    Go to article

    Colon to Rectum

    Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF-experienced ulcerative colitis patients: A nationwide Dutch Registry study

    Clin Gastroenterol Hepatol. 2023;21(1):182–91.e2

    Straatmijer T, Biemans VBC, Visschedijk M, Hoentjen F, de Vries A, van Bodegraven AA, Bodelier A, de Boer NKH, Dijkstra G, Festen N, Horjus C, Jansen JM, Jharap B, Mares W, van Schaik FDM, Ponsioen C, Romkens T, Srivastava N, van der Voorn MPJA, West R, van der Woude J, Wolvers MDJ, Pierik M, van der Meulen-de Jong AE, Duijvestein M; Initiative on Crohn and Colitis

    Go to article

    Colon to Rectum

    Early management of acute severe UC in the biologics era: Development and international validation of a prognostic clinical index to predict steroid response

    Gut. 2023;72(3):433–42

    Adams A, Gupta V, Mohsen W, Chapman TP, Subhaharan D, Kakkadasam Ramaswamy P, Kumar S, Kedia S, McGregor CGC, Ambrose T, George BD, Palmer R, Brain O, Walsh A, Ahuja V, Travis SPL, Satsangi J

    Go to article

    Colon to Rectum

    Increasing incidence of pouchitis between 1996 and 2018: A population-based Danish cohort study

    Clin Gastroenterol Hepatol. 2023;21(1):192–9.e7

    Barnes EL, Allin KH, Iversen AT, Herfarth HH, Jess T

    Go to article

    Colon to Rectum

    Risk factors for developing inflammatory bowel disease within and across families with a family history of IBD

    J Crohns Colitis. 2023;17(1):30–6

    Torres J, Gomes C, Jensen CB, Agrawal M, Ribeiro-Mourão F, Jess T, Colombel JF, Allin KH, Burisch J

    Go to article

    Colon to Rectum

    Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: The prospective ERIca trial

    Gastroenterology. 2023;164(2):241–55

    Rath T, Atreya R, Bodenschatz J, Uter W, Geppert CE, Vitali F, Fischer S, Waldner MJ, Colombel JF, Hartmann A, Neurath MF

    Go to article